Kaufmann Hitto 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Mar 8, 2021
Insider Transaction Report
Form 4
Kaufmann Hitto
SVP, Chief Scientific Officer
Transactions
- Award
Stock Options (Right to buy)
2021-03-04+220,000→ 220,000 totalExercise: $2.50Exp: 2031-03-04→ Common Stock (220,000 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the option shares on March 4, 2022 and as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.